Cleared Traditional

LEOCOR GUIDING CATHETER (K911270) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K911270 · Leocor, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1992
Decision
301d
Days
Class 2
Risk

K911270 is an FDA 510(k) clearance for the LEOCOR GUIDING CATHETER. Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by Leocor, Inc. (Houston, US). The FDA issued a Cleared decision on January 17, 1992 after a review of 301 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1200 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Leocor, Inc. devices

Submission Details

510(k) Number K911270 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 22, 1991
Decision Date January 17, 1992
Days to Decision 301 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
176d slower than avg
Panel avg: 125d · This submission: 301d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 154
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K911270.
DESERET GUIDEWIRE INTRODUCER III
K920408 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Apr 1992
CORDIS 5.0 FRENCH SUPER TORQUE CATHETERS
K915836 · Cordis Corp. · Feb 1992
TERUMO ANGIOGTAPHIC CATHETER
K915414 · Terumo Medical Corp. · Feb 1992
MERIT DISPOSAL DEPOT(TM)
K914208 · Merit Medical Systems, Inc. · Dec 1991
FLOSWITCH(R) HP
K913871 · Boston Scientific Corp · Nov 1991
MERIT CUSTOM KIT
K913682 · Merit Medical Systems, Inc. · Nov 1991